These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19304122)

  • 1. Levels of serum deoxyribonuclease I activity on admission in patients with acute myocardial infarction can be useful in predicting left ventricular enlargement due to remodeling.
    Kuribara J; Tada H; Kawai Y; Kawaguchi R; Hoshizaki H; Arakawa K; Kitayama M; Kajinami K; Kurabayashi M; Oshima S; Taniguchi K; Kominato Y; Yasuda T
    J Cardiol; 2009 Apr; 53(2):196-203. PubMed ID: 19304122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction.
    Kawai Y; Yoshida M; Arakawa K; Kumamoto T; Morikawa N; Masamura K; Tada H; Ito S; Hoshizaki H; Oshima S; Taniguchi K; Terasawa H; Miyamori I; Kishi K; Yasuda T
    Circulation; 2004 May; 109(20):2398-400. PubMed ID: 15148274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
    Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
    J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.
    Matsunaga T; Abe N; Kameda K; Hagii J; Fujita N; Onodera H; Kamata T; Ishizaka H; Hanada H; Osanai T; Okumura K
    Int J Cardiol; 2005 Nov; 105(2):203-8. PubMed ID: 16243114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function.
    Suezawa C; Kusachi S; Murakami T; Toeda K; Hirohata S; Nakamura K; Yamamoto K; Koten K; Miyoshi T; Shiratori Y
    J Lab Clin Med; 2005 Jan; 145(1):33-40. PubMed ID: 15668659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum deoxyribonuclease I activity can be a useful diagnostic marker for the early diagnosis of unstable angina pectoris or non-ST-segment elevation myocardial infarction.
    Fujibayashi K; Kawai Y; Kitayama M; Akao H; Ishida R; Motoyama A; Wakasa M; Arakawa K; Ueki M; Kajinami K; Yasuda T
    J Cardiol; 2012 May; 59(3):258-65. PubMed ID: 22365949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention.
    Arakawa K; Kawai Y; Kumamoto T; Morikawa N; Yoshida M; Tada H; Kawaguchi R; Taniguchi K; Miyamori I; Kominato Y; Kishi K; Yasuda T
    Eur Heart J; 2005 Nov; 26(22):2375-80. PubMed ID: 15821005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of admission white blood cell count to left ventricular remodeling after anterior wall acute myocardial infarction.
    Bauters A; Ennezat PV; Tricot O; Lallemant R; Aumégeat V; Segrestin B; Quandalle P; Lamblin N; Bauters C;
    Am J Cardiol; 2007 Jul; 100(2):182-4. PubMed ID: 17631066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum deoxyribonuclease I can be used as a useful marker for diagnosis of death due to ischemic heart disease.
    Yasuda T; Iida R; Kawai Y; Nakajima T; Kominato Y; Fujihara J; Takeshita H
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S213-5. PubMed ID: 19254870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction.
    Orn S; Manhenke C; Anand IS; Squire I; Nagel E; Edvardsen T; Dickstein K
    Am J Cardiol; 2007 Apr; 99(8):1109-14. PubMed ID: 17437737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
    Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
    Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction.
    Tziakas DN; Chalikias GK; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris A; Hatseras DI; Kaski JC
    Am J Cardiol; 2005 Jul; 96(1):31-4. PubMed ID: 15979428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: do they affect the outcome of patients?
    Oren H; Erbay AR; Balci M; Cehreli S
    Angiology; 2007; 58(1):45-54. PubMed ID: 17351157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction.
    Sato A; Aonuma K; Imanaka-Yoshida K; Yoshida T; Isobe M; Kawase D; Kinoshita N; Yazaki Y; Hiroe M
    J Am Coll Cardiol; 2006 Jun; 47(11):2319-25. PubMed ID: 16750702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate variability and left ventricular dilatation early after myocardial infarction.
    Nishiue T; Tsuji H; Tarumi N; Tokunaga S; Tamura K; Masaki M; Inada M; Iwasaka T
    J Electrocardiol; 1999 Jul; 32(3):263-8. PubMed ID: 10465569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
    Savoye C; Equine O; Tricot O; Nugue O; Segrestin B; Sautière K; Elkohen M; Pretorian EM; Taghipour K; Philias A; Aumégeat V; Decoulx E; Ennezat PV; Bauters C;
    Am J Cardiol; 2006 Nov; 98(9):1144-9. PubMed ID: 17056315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.